期刊文献+

复方通络中药改善肥胖患者血管内皮细胞功能障碍研究 被引量:2

Research on the Effect of Chinese Herbal Meridian Deoppilant Compound on Vascular Endothelial Cell Dysfunction of Obese Patients
下载PDF
导出
摘要 目的观察复方通络中药对单纯性肥胖患者血管内皮依赖性舒张功能障碍的干预效应,探讨其作用机制。方法应用高分辨血管超声检查选择血管内皮依赖性舒张功能障碍[以血流介导的肱动脉扩张率(FMD)表示]肥胖患者(65例),随机分为通络中药治疗组和对照组。治疗组32例,对照组33例。治疗组给予辛香疏络2号胶囊,3g/次,每日3次;对照组给予淀粉胶囊,3g/次,每日3次。共用药12周,分别测定用药前后FMD、肱动脉内径(DO),同时检测辛香疏络2号治疗前后患者血清总胆固醇(TC)、三酰甘油(TG)的变化。结果治疗后治疗组FMD较对照组明显增加(P < 0.01),TC、 TG较治疗前及对照组明显下降(P<0.01)。结论复方通络中药辛香疏络2号胶囊可明显改善肥胖患者血管内皮障碍,调节血脂可能是其改善血管内皮功能机制之一。 Objective To observe the effects of Chinese herbal meridian and vessel deoppilant compound on the dysfunction of endothelium-dependent dilation (EDD) of simple obesity patients, and explore its mechanism. Methods Sixty-five obese patients with dysfunction of EDD (denoted by FMD: flow mediated brachial artery vasodilatation rate) were found through the preliminary high-resolution vascular ultrasound check, and randomized into the therapy group (treated with Chinese herbal meridian and vessel deoppilant compound) and the control group. The therapy group took Xinxiang Shuluo 2# capsules three times a day, 3 gram each time, and the control group was given the same doses of starch capsules. The experiment lasted 12 weeks. Before and after the experiment, FMD and inner diameter of brachial arteries (DO) of all the patients were measured, and the changes of total cholesterol (TC) and trigiyceride (TG) in serum were compared. Results FMD of the therapy group was significantly higher than the control group (P〈O.01). TC and TG levels of the therapy group were significantly lower than before the treatment and the control group (P〈0.01). Conclusion EDD has been significant improved after the treatment of Chinese herbal meridian and vessel deoppilant compound, which can markedly relieve the vascular endothelial malfunction of obese patients, and blood-lipid regulation may be the one of the functional mechanisms.
出处 《中国中医药信息杂志》 CAS CSCD 2009年第12期8-10,共3页 Chinese Journal of Information on Traditional Chinese Medicine
基金 国家中医药管理局基金(04-05LP09)
关键词 肥胖 内皮功能障碍 血脂 复方通络中药 辛香疏络2号胶囊 obesity endothelial dysfunction blood lipid Chinese herbal meridian deoppilant compound Xinxiang Shuluo 2# capsules
  • 相关文献

参考文献8

二级参考文献56

  • 1陈静,张素华,任伟,李革,马贵成,卢仙娥,李启富,包柄楠,王继旺,杜娟,邓吉容,唐兰,苗青.重庆地区3388个自然人群肥胖与相关疾病的关系调查[J].重庆医学,2004,33(10):1508-1510. 被引量:17
  • 2Libby P. Ridker PM. Novel inflammatory markers of coronary risk:theory versus praetice[J]. Circulation, 1999,100:1148-1150.
  • 3Ross R. Atherosclerosis --- an inflammatory disease[J]. N Engl J Med 1999,340:115-126.
  • 4Masen A. Inflammation, atherosclerosis and ischemic events --- exploring the hidden side of the moon[J]. N Eng J Med, 1997:336:1014-1016.
  • 5Rus HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human atheresclerotic wall[J]. Atherosclerosis , 1996,127: 263-271.
  • 6Yudkin JS, Kumari M, Humphries SE, et al. Inflammation, obesity, stress and coronary heart disease: is interleukin.6 the link[J]?Atherosclerosis, 2000,148:209-214.
  • 7Skretting G, Gjemes E, Prydz H. Regulation of lecithin:Cholesterol acyltransferase by TGF-beta and interleukin-6[ J]. Biochem Biophys Acta, 1995,1255 : 267-272.
  • 8Biasucci LM, Vitelli A, Livzzo G, et al. Elevated levels of interleukin-6 in unstable angina[J]. Circulation, 1996,94:874-877.
  • 9Ridker PM, Rifai N, Stampfer M J, et al. Plasma concentration interleukin-6 and the risk eft future myocardial iffarction among apparently healthy men[J]. Circulation, 2000,101 : 1767-1772.
  • 10Weber C, Erl w, Weber KSC, et al. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesives of monocytes isolated from patients with hypercholesterolemia[ J]. J Am coll Cardiol,1997,30:1212-1217.

共引文献123

同被引文献18

  • 1陶军.肥胖与血管内皮功能和内皮祖细胞的关系[J].中国医学前沿杂志(电子版),2011,3(2):7-9. 被引量:2
  • 2赵湜,王红祥,李宾公,毛红,邵诗颖.糖尿病周围血管病血管内皮祖细胞数量和功能的改变及其机制探讨[J].中国糖尿病杂志,2007,15(1):42-43. 被引量:14
  • 3刘旭东,胡厚源.超重对中青年原发性高血压患者血管内皮功能的影响[J].现代中西医结合杂志,2007,16(15):2044-2045. 被引量:2
  • 4Hunting CB, Noort WA, Zwaginga JJ. Circulating endothelial( progen- itor) ceils reflect the state of the endothelium: Vascular injury, repair and neovascularization [ J ]. Vox Sang, 2005, 88 (1) : 1 -9.
  • 5Beelen DW, Ottinger H, Kolbe K, et al. Filgrastim mobilization and collection of allogeneic blood progenitor cells from adult family donors : First interim report of a prospective German multicenter study [ J ]. Ann Hematol, 2002, 81 (23) : 701 -709.
  • 6Maruotti G M,Rizzo G,Sirico A , et al. Are there any rela-tionships between umbilical artery Pulsatility Index andmacrosomia in fetuses of type I diabetic mothers . [ J ]. TheJournal of Maternal-Fetal & Neonatal Medicine,2014,27(17): 1776-1781 .
  • 7Liao Y,Feng Y,Chen LL , et al. Coronary heart diseaserisk equivalence in diabetes and arterial diseases character-ized by endothelial function and endothelial progenitor cell[J ]. Journal of Diabetes and its Complications , 2014 , 28(2): 214-218.
  • 8Bibra HV , Paulus WJ , Sutton MSJ,et al. Quantification ofdiastolic dysfunction via the age dependence of diastolicfunction-Impact of insulin resistance with and without type2 diabetes [ J ]. International journal of cardiology , 2015 (182):368-374.
  • 9Stuart MJ , Baune BT. Depression and type 2 diabetes : in-flammatory mechanisms of a psychoneuroendocrine co-morbid-ity [ J ]. Neuroscience & Biobehavioral Reviews,2012,36 (1):658-676.
  • 10胡丽叶,朱旅云,李晓玲,马利成,单巍,王广宇.超重/肥胖人群血管内皮功能的六年随访研究[J].临床内科杂志,2009,26(1):44-46. 被引量:2

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部